GenTech's Research
At GenTech Analytica, we are pioneering genetic research in the Caribbean. Our work involves genome-wide association studies (GWAS), polygenic risk scores (PRS), and a focus on uncovering genetic diversity unique to the region, with the goal of better understanding health risks in Caribbean populations.
Research Papers
An Analysis into 23andMe Journey and Data Security Challenges
The study provides an analysis on the defining factors of 23andMe's success as well as the failures which led to their downfall.
Written by: Rhea Barret, Junior Researcher
Latest Blogs
Early Warning Signs of Prostate Cancer: What Every Caribbean Man Should Know
11/9/2024 | Devy Frederick
Understanding Common Symptoms and Early Warning Signs
Read More
Understanding Prostate Cancer in Caribbean Men: Why Genetics Matter
11/9/2024 | Devy Frederick
Why Are Black Men at a Higher Risk of Developing Prostate Cancer?
Read MoreJoin Our Study
Caribbean Prostate Cancer Whole Genome Study
Duration: 12 – 24 months
Eligibility: Men 18+ with 4 Caribbean grandparents
Location: St. Lucia
Estimated Participants: 150 participants
Estimated Completion: December 31, 2025
Design: Novel Genetic Marker Discovery
Conducted by: CariGenetics, Tapion Hospital, GenTech Analytica
This study aims to identify unique prostate cancer genetic markers for Caribbean men, contributing to more specific predictive screening and earlier interventions.